Picture of Travere Therapeutics logo

TVTX — Travere Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Travere Therapeutics Q2 EPS USD -0.91 Vs. IBES Estimate USD -0.86

Aug 01 (Reuters) - Travere Therapeutics Q2 operating income USD -67.704
million vs. IBES estimate USD -64.6 million.
* Q2 net income USD -70.409 million
* Q2 product sales USD 52.176 million vs. IBES estimate USD 50.2 million
* Q2 operating expenses USD 121.82 million

Recent news on Travere Therapeutics

See all news